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Abstract
2-Butylamino-2-demethoxy-hypocrellin A (BAHA) and B (BAHB) are new photosensitizers synthesized by a mild reaction
of hypocrellins and butylamine. In BAHA and BAHB, the peri-hydroxylated perylenequinone structure of the parent
hypocrellins is preserved and the red absorption is enhanced distinctly. Electron paramagnetic resonance spin trapping
measurements and 9,10-diphenylanthracene bleaching studies were used to investigate the photodynamic action of BAHA
and BAHB in the presence of oxygen. Singlet oxygen (1O2) and superoxide anion radical (Oc32 ) produced by illuminating
BAHA and BAHB in aerobic solution have been observed. Compared with hypocrellin A and B, BAHA and BAHB
primarily remained able to generate 1O2 and enhanced distinctly the Oc32 -generating abilities. The photodynamic action of
BAHA and BAHB in the therapy of cancer was investigated in vitro and in vivo. Both in vitro and in vivo results revealed a
significant decrease in cancer cell growth. Laser or dye alone had no effect, indicating that intratumor BAHA and laser
therapy may prove useful in unresectable cancer. ß 2001 Elsevier Science B.V. All rights reserved.
Keywords: Hypocrellin; Photodynamic therapy; Pancreatic adenocarcinoma cancer; Electron paramagnetic resonance
1. Introduction
Photofrin is the only photosensitizer to be ap-
proved by the US FDA so far [1]. The naturally
occurring polycyclic quinones, hypocrellins (includ-
ing hypocrellin A and B) (Fig. 1), have gained con-
siderable attention because of their light-induced
antitumor and antiviral activities, most notably
against the human immunode¢ciency virus, HIV
[2,3]. The possible role of labile protons in the photo-
dynamic activity of the polycyclic quinones was dis-
cussed in detail in the literature [4^7]. The hypocrel-
lins exhibit several advantages over Photofrin,
including ready preparation, easy puri¢cation, low
aggregation tendency and rapid metabolism in vivo
[8,9]. However, their low absorption in the photody-
namic window (600^900 nm) limits their application
in photodynamic therapy (PDT).
In the last 20 years, a variety of hypocrellin deriv-
atives were demonstrated to be photodynamically
active and e⁄cient 1O2 generators [10^14]. It was
found that some amino-substituted hypocrellin deriv-
atives reported by Z.J. Diwu possessed higher photo-
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dynamic activity than the other derivatives [15].
However, the original peri-hydroxylated perylenequi-
none structure of hypocrellin was modi¢ed by the
amino substitution, which impeded the intramolecu-
lar proton transfer process.
In the present paper 2-butylamino-2-demethoxy-
hypocrellin A (BAHA) and B (BAHB) were synthe-
sized by a mild method (Fig. 2), in which the peri-
hydroxylated perylenequinone structure of parent
hypocrellins was preserved and the photoresponse
of the dye was enhanced markedly. Their photo-
chemical and photobiological properties were
studied. HeLa, MGC803 and human pancreatic tu-
mor cell line Capan-1 cells were employed to inves-
tigate the phototoxicity of BAHA and BAHB in vi-
tro, and the photodynamic therapy of transplanted
human pancreatic cancer on nude mice in vivo was
performed using BAHA as the sensitizer. Satisfactory
results were obtained.
2. Materials and methods
2.1. Chemicals
HA was isolated from the fungus sacs of
Hypocrella bambusae and recrystallized twice from
acetone before use. HB was prepared by dehydration
of HA in alkaline solution [16]. 5,5-Dimethyl-1-
pyrroline-N-oxide (DMPO), 2,2,6,6-tetramethyl-4-
piperidone (TEMP), p-benzoquinone (PQ), 9,10-di-
phenylanthracene (DPA) and 1,4-diazabicyclo[2,2,2]-
octane (DABCO) were purchased from Aldrich
(Milwaukee, WI, USA). All the solvents were pur-
chased from Beijing Chemical Plant (Beijing, PR
China).
2.2. Measurements
Ultraviolet-visible (UV-Vis) absorption spectra
were recorded with a Shimadzu UV-160A spectro-
photometer. Infrared (IR) spectra were measured
with a Perkin-Elmer 557 grating spectrophotometer.
Mass spectra (MS) were conducted on FAB MS
AEI-MS 50 Kratons and proton nuclear magnetic
resonance (1H-NMR) spectra were recorded with a
Varian XL-300 spectrophotometer.
2.3. Synthesis of BAHA and BAHB (Fig. 2)
Hypocrellin A or B (300 mg) was dissolved in
freshly distilled pyridine (120 ml) containing n-butyl-
amine (15 ml) and the resulting solution was stirred
for 15 h at 50^55‡C in the dark. The solvent was
removed under reduced pressure. Then chloroform
was added and the solution was washed with dilute
hydrochloric acid several times until the pH value of
the water layer was neutral. Chloroform was evapo-
rated to a¡ord a brown solid, which was separated
by TLC on a 1^2% KH2PO4 silica gel plate using
petroleum ether/ethyl acetate/95% ethanol (4:2:1
v/v/v) as eluent. The products BAHy (BAHA and
BAHB) were obtained and identi¢ed by satisfactory
data of 1H-NMR, UV-Vis, IR and mass spectra.
2.4. Cyclic voltammogram measurement
Potentiostat/Galvanostat Model 283 from EGpG
Instrument was used here. The counter electrode was
a Pt spiral and the reference electrode a saturated
calomel electrode (SCE). The supporting dielectric
solution was 0.1 mol/l lithium perchlorate^acetoni-
trile solution.
Fig. 1. Structures of hypocrellin A and B.
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2.5. Determination of active oxygen species
generation
Electron paramagnetic resonance (EPR) spectra
were recorded with a Bruker Model ESP 300E spec-
trometer at room temperature. Samples were intro-
duced into the specially made quartz cup and illumi-
nated directly inside the microwave cavity. All
samples were purged with puri¢ed O2 for 30 min in
the dark and irradiated directly in the cavity of the
EPR spectrometer with a Q-switched Nd:YAG
nanosecond laser apparatus (full width at half-max-
imum, 35 mJ pulse31 ; V= 532 nm).
The EPR measurement of spin trapping by TEMP
was employed to determine the formation of 1O2 by
the sensitizers [17]. Typically, the reaction solution
consisted of 0.1 mM sensitizer and 20 mM TEMP.
The DPA bleaching method was used to con¢rm the
1O2 generation quantum yields further; the details
have been described in a previous report [18]. The
photo-oxidation of DPA sensitized by a sensitizer
was carried out on a ‘merry-go-round’, in which
the samples were illuminated by 436 nm light. These
two methods gave consistent results.
The EPR measurement of spin trapping of DMPO
was used to detect the generation of Oc32 by BAHy
[19]. Typically, the reaction solution consisted of
1 mM BAHy and 40 mM DMPO.
2.6. HeLa and MGC803 cell survival studies
Cell survival was estimated by the MTT assay
[20,21]. Cells were transferred to £at-bottomed 96-
well plates, 100 Wl in each well containing 1000 cells.
Twenty hours later, 10 Wl of MTT solution (10 mg/
ml in fetal bovine serum (PBS)) were introduced into
the wells for 4 h at 37^38‡C. The wells were drained
carefully and 150 Wl DMSO were added per well to
prevent MTT reduction and to dissolve the blue for-
mazan crystals produced by mitochondrial hydroge-
nases in living cells only. The plate was shaken at
room temperature for 10 min and read immediately
at 595 nm on a Bio-Rad model 3550 microplate read-
er. Samples of BAHA were measured in 12 replicates
and each experiment was repeated at least twice. Sur-
vival of PDT-treated cells was normalized against
cells incubated with photosensitizer alone. The dark
toxicity was assessed separately, and a similar proce-
dure for cell exposure to graded doses of the photo-
sensitizers for 4 h was followed.
2.7. Capan-1 cell survival study
Human pancreatic tumor Capan-1 cells were pre-
sented by the Department of Visceral and Transplan-
tation Surgery, University of Bern, Switzerland.
The cells were cultured in RPMI 1640 medium
supplemented with 5% FBS, 100 Wg/ml of penicillin,
100 Wg/ml of streptomycin at 37‡C in a Forma
Scienti¢c water-jacketed 5% carbon dioxide incuba-
tor.
Exponentially growing cells in 35 mm dishes
(NUC) were incubated with increasing concentra-
tions of BAHB from 2U1036 M to 16U1036 M in
RPMI 1640 medium (FBS-free) for 4 h. The cells
were irradiated with di¡erent doses of light from
2 J/cm2 to 16 J/cm2. The control group contained
cells without laser treatment. A second group of con-
trols underwent treatment with He-Ne632.8 laser
therapy without addition of BAHB. The light source
was a Red light Treatment Instrument (Institute of
Electronics, Academia Sinaca China); its total power
output was more than 90% of the ampul. After irra-
diation, the cells were placed in RPMI 1640 medium
containing 5% FBS and incubated for 24 h before
survival assessment. Cells survival was estimated by
the MTT assay as mentioned above.
2.8. Animal model
Six-week-old athymic mice were purchased from
the Institute of Animal Model, Chinese Academy
of Medical Sciences and quarantined for 4 days in
¢lter top cages. Twelve hour light/dark cycles were
maintained in the mice facility. Mice had free access
to water and rodent chow at all times during the
experiment. The mice consisted of females and males
and weighed between 16 and 18 g.
2.9. Intratumor photodynamic therapy of
subcutaneous and transplanted human
pancreatic tumor nodules
2.9.1. Subcutaneous tumor implantation
Capan-1 cells were trypsinized and washed twice
with RPMI 1640 before resuspension in medium and
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counted on a hemocytometer. Mice underwent sub-
cutaneous injection of 1 million cells in 200 Wl of
RPMI 1640 in the underbelly. Forceps were used
to pinch the skin closed after injection of Capan-1
cells to prevent leakage of cells. Mice were main-
tained for 4 weeks after implantation of human pan-
creatic cancer cells to allow growth of tumor nod-
ules.
2.9.2. Animal grouping
When the nodule grew up to approx. 0.2 cm3,
the nude mice were grouped stochastically: group
A: no treatment was applied to the nude mice;
group B: only laser light was applied to the nude
mice; group C: photodynamic therapy with HA
and laser light was applied to the nude mice; group
D: the same as group C but HA was replaced by
BAHA.
2.9.3. Intratumor photodynamic therapy of
subcutaneous human pancreatic tumor nodules
After a 1.5 month incubation period and growth
of human pancreatic cancer nodules, a subset of mice
were randomly injected with DMSO solution of dye
30 mg/kg and kept in the dark for 2 h. Light gener-
ated by a He-Ne pumped dye laser (632.8 nm) was
supplied on the sole tumor area via a quartz ¢ber,
which delivered 100 mW. Mice underwent intraperi-
toneal injections of 0.20 ml of anesthesia consisting
of 1.0 ml 70% ethanol, 6.0 ml distilled water, and 1.6
ml sodium pentobarbital as previously reported [22].
Tumor nodules were measured in three dimensions
by calipers. A minilaparotomy was performed in the
upper abdomen to allow direct measurement of in-
trapancreatic tumors prior to injection of sensitizer.
The measurements obtained at the 21 day interval
served as the control size. Tumors received one
dose of 120 J each of laser light for 20 min set at
100 mW. Mice were allowed to recover after photo-
dynamic therapy treatments. Mice were sacri¢ced 21
days after laser treatment and tumors measured by
calipers in three dimensions.
3. Results and discussion
3.1. Characteristics of BAHA and BAHB
Amination of hypocrellins (including HA and HB)
in pyridine a¡orded the aminated hypocrellins BAHy
(Fig. 2). The chemical structure of hypocrellins sug-
gests three possible reaction sites, such as the aro-
matic ring, quinonoid carbonyl groups and the at-
tached ring. Based on UV, IR, 1H-NMR and MS
data, the aminated hypocrellins were identi¢ed to
be 2-butylamino-2-demethoxy HA (BAHA) and HB
(BAHB). For BAHA: FAB MS (M, 587); IR cm31
(KBr, Xmax): 3419, 2922, 1680, 1608; UV-Vis:
([CDCl3] Vmax, nm [log O]) : 466 (4.05), 577 (4.12),
641 (4.06); 1H-NMR (300 MHz, CDCl3) N (ppm)
1.00 (3H, t, CH3-22), 1.49 (2H, m, CH2-21), 1.68
(2H, m, CH2-20), 1.79 (3H, s, 16-CH3), 1.91 (3H,
s, CH3-18), 2.55 (1H,d, H-13a), 3.08 (1H,d, H-13b),
3.60 (2H, m, NCH2), 4.01 (3H, s, OCH3-6), 4.08 (3H,
Fig. 2. Pathway for the amination of hypocrellin A and B.
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s, OCH3-7), 4.15 (3H, s, OCH3-11), 6.32 (1H, s, H-
5(8)), 6.80 (1H, s, H-8(5)), 15.78 (1H, OH-9(10)),
16.07 (1H, OH-3(4)); for BAHB: FAB MS (M,
569); IR cm31 (KBr, Xmax): 3340, 2922, 1706,
1600; UV-Vis: ([CDCl3] Vmax, nm [log O]) : 463
(4.06), 583 (4.09), 621 (4.10); 1H-NMR (300 MHz,
CDCl3) N (ppm) 1.07 (3H, t, CH3-22), 1.50 (2H, m,
CH2-21), 1.78 (3H,s, CH3-16), 1.95 (2H, m, CH2-20),
2.34 (3H, s, CH3-18), 2.80 (1H, d, H-13a, JAB = 11.5),
3.70 (2H, m, NCH2), 3.90 (1H, d, H-13b, JAB = 11.5),
4.05 (6H, s, OCH3-6,7), 4.09 (3H, s, OCH3-11), 6.38
(1H, s, H-5(8)), 6.60 (1H, s, H-8(5)), 15.8 (1H, OH-
9(10)), 16.1 (1H, OH-3(4)).
3.2. Absorption spectra
Hypocrellins exhibited three absorption bands at
450 nm, 535 nm, and 584 nm in the region of the
wavelength between 400 and 800 nm. When an elec-
tron-donating butylamino group was introduced into
the hypocrellin molecules, the longer wavelength ab-
sorption band at 584 nm was enhanced markedly
and a new band at 628 nm appeared, which ex-
panded the photoresponse of hypocrellins that was
essential for the photodynamic agents. The charac-
teristics of the absorption spectra of BAHy are de-
picted in Table 1.
3.3. EPR measurements of active oxygen species
generated during the photosensitization of BAHA
and BAHB
3.3.1. Generation of singlet oxygen species
Illumination of BAHy (0.1 mM) containing 10
mM TEMP, an e⁄cient 1O2 tripper [17], in an oxy-
gen-saturated DMSO solution with 532 nm laser at
room temperature led to the generation of a strong
EPR signal (Fig. 3). The intensity of the EPR signals
increased rapidly during photoirradiation and de-
creased very slowly in the dark and it depended on
the concentration of the sample and the illumination
time. As shown in Fig. 3, an EPR spectrum of three
equal intensity lines, characteristic of a nitroxide rad-
ical, was observed. The g factor and hyper¢ne split-
ting constant (aN = 13.8 G) of the EPR signals were
Fig. 3. Intensity of the spin adduct TEMPO against duration of laser (532 nm excitation) exposure for di¡erent sensitizers in aerobic
chloroform. A, BAHA (0.1 mM); B, BAHB (0.1 mM); C, HA (0.1 mM); D, HB (0.1 mM); E, in the presence of DABCO (0.5 mM).
Spectrometer settings: microwave power, 5 mW; modulation amplitude, 10 G; time constant, 0.128 s.
Table 1
Absorption spectra characteristics of hypocrellins and their ami-
nated hypocrellins (in chloroform)
Compound Absorption wavelength (nm) [log O]
HA 465 [4.46], 539 [4.12], 580 [4.11]
HB 466 [4.36], 548 [3.70], 580 [3.52]
BAHA 466 [4.05], 577 [4.12], 641 [4.06]
BAHB 463 [4.06], 583 [4.09], 621 [4.10]
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found to be same as those of authentic TEMPO [17].
Therefore, the EPR signals generated during the ir-
radiation of the BAHy solution containing TEMP
were attributed to TEMPO. Thus, 1O2 should be
implicated in the formation of TEMPO. The EPR
signals were suppressed by 1O2 scavengers, such as
DABCO, further con¢rming that TEMPO was de-
rived from the reaction of TEMP with 1O2 generated
by the irradiation of BAHy. Control experiments in-
dicated that BAHy, oxygen and light were all essen-
tial for the formation of TEMPO, indicating that the
formation of the nitroxide radical was a photody-
namic process. The quantum yields of 1O2 generation
(Table 2) were further determined by the DPA
bleaching method with HB as the reference
(x 1O2 = 0.76) [18], as well as by EPR measurements.
1
The reaction was followed spectrometrically by ob-
serving the decrease of the absorbance of DPA at
376 nm (where HA, HB and BAHy all have the low-
est absorption) as a function of irradiation time.
3.3.2. Generation of superoxide anion radical
Illumination of an oxygen-saturated DMSO solu-
tion of BAHy (0.1 mM) and DMPO (40 mM) with
laser (V= 532 nm) in the EPR cavity gave rise to a
typical 3U2U2 EPR spectrum (Fig. 4), which was
the characteristic of the DMPO/cOOH radical adduct
[19]. In the presence of p-benzoquinone, which acted
as an Oc32 quencher [23], the EPR signals were inhib-
ited, which con¢rmed the formation of superoxide
anion radical detected by the DMPO spin trap.
Fig. 4 shows that the generation ability of superoxide
of BAHy was at least 3 times as e¡ective as that of
the parent hypocrellins. As we know, Oc32 could be
produced by hypocrellins via the reaction shown in
Eqs. 2, 3 and 4. When the butylamino group was
introduced into the hypocrellin molecule, the oxida-
tion potential of the dyes decreased to 0.83 V
(BAHA) and 0.81 V (BAHB) from 1.35 V (HA)
and 1.32 V (HB) compared with their parent com-
pounds (Table 3), which made the electron transfer
Fig. 4. Intensity of the spin adduct superoxide during irradiation of a DMSO solution of hypocrellins in the presence of DMPO (50
mM). A, BAHA (0.1 mM); B, BAHB (0.1 mM); C, HA (0.1 mM); D, HB (0.1 mM). Spectrometer settings are the same as in Fig. 3.
Table 2
Quantum yields of 1O2 generation by hypocrellins and their
aminated hypocrellins
Compound Quantum yield (1O2)
HA 0.80
HB 0.76
BAHA 0.46
BAHB 0.44
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readily from the excited state of BAHy to the oxygen
molecule as shown in Eq. 5 (vG =30.30 eV6 0),
while for hypocrellins this is not allowed thermody-
namically (vGs 0). It may explain the enhancement
of the Oc32 generation ability of BAHy.
BAHy hX! BAHy 2
BAHy  BAHy! BAHyc  BAHyc3 3
BAHyc3 O2 ! BAHyOc32 4
BAHy O2 ! BAHyc Oc32 5
3.4. HeLa and MGC803 cell survival studies
Some earlier studies have reported the photopoten-
tiation factors (LD50 dark/LD50 light) of parent hy-
pocrellins and their 16 new derivatives, in which HA
was characterized by 4-fold photopotentiation [24].
The photopotentiation factors of HA and BAHA
were studied by Zhang Zhiyi et al., our co-workers,
who chose a dose of 4 J/cm2 red light for further
studies, since at this dose HA also demonstrated
about 4-fold photopotentiation in our study as de-
scribed above. The cell survival studies of HA and
BAHA have been reported [25]. The MGC803 and
HeLa cancer cells were employed to study the photo-
biological properties of HB and its aminated deriva-
tive. BAHB exhibited much higher phototoxicity
than their parent hypocrellins, with 50% cell killing
at a concentration of 0.25^0.5 WM at a light dose of
4 J/cm2. Therefore BAHy were characterized by 100^
200- and 200^400-fold photopotentiation factor, re-
spectively. The detailed results, which are shown in
Table 4, quali¢ed BAHy as more ideal photodynamic
therapeutic anti-cancer agents than their parent hy-
pocrellins.
3.5. Human pancreatic cancer in vitro and in vivo
Pancreatic adenocarcinoma remains one of the
devastating neoplasms of the gastrointestinal tract.
The incidence of pancreatic cancer is nine per
100 000 and has remained steady since 1973 [26,27].
With an overall median survival of 6 months and
a discouraging 5 year survival rate after radical
surgery, the prognosis in pancreatic cancer remains
pessimistic [28,29]. Adjunctive treatment to pancreat-
ic resection has extended life approx. 9 months [30].
Intraoperative radiotherapy in conjunction with
resective surgery has reported 5 year survival rates
of 15.3^20.2% [31]. The search for other treat-
ment modalities may alter the outcome of patients
with pancreatic malignancies. Owing to the rela-
tively selective targeting of neoplastic tissue reported
in the literature [32], PDT was regarded as a promis-
ing method. We hypothesized that BAHy and
laser phototherapy would decrease pancreatic cancer
growth.
3.5.1. Capan-1 cell survival study
Without light illumination BAHB did not a¡ect
tumor cell growth distinctly. With red light stimula-
tion, BAHB appeared e¡ective in a dose-dependent
manner from 0 to 16U1036 mol/l (above 90% inhi-
bition in three cell lines) (Fig. 5). The survival rate of
Table 4
Results of the cell survival studies of hypocrellins and their aminated hypocrellins
Compound Dark toxicity LD50 (WM) Phototoxicity LD50 (WM) Photopotentiation factors
HA 17 4.25 4
HB 20 2 10
BAHA 100 0.25^1.0 100^200
BAHB s 100 0.25^0.5 200^400
Table 3
Relevant redox potentials and singlet state energy of hypocrel-
lins and their aminated hypocrellins
Compound EOX (V) ERe (V) E0ÿ0 (eV)
HA 1.35 30.58 1.84
HB 1.32 30.53 1.82
BAHA 0.83 30.53 1.63
BAHB 0.81 30.51 1.60
O2 30.50
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PDT for the Capan-1 cells decreased along with the
increase of the concentration of BAHB and dose
of light. Under low concentration of BAHB the
curve declined rapidly, and slowed down to reach a
plateau. An early and strong necrosis of Capan-1
cells in vitro was achieved after PDT at 16 J/cm2,
in spite of a relatively low dye concentration
(2U1036 mol/l).
3.5.2. Intratumor photodynamic therapy of
subcutaneous human pancreatic tumor nodules
3.5.2.1. Growth of pancreatic tumor nodules. In-
cubated with pancreatic cells, the nodules appeared
and accrued rapidly after 1 week incubation period.
When the nodule grew up to approx. 0.2 cm3, its
volumes were listed and the nude mice were distrib-
uted for further treatment.
3.5.2.2. Intratumor photodynamic therapy of subcu-
taneous human pancreatic tumor nodules. Fig. 6
shows that there were no perceptible di¡erences be-
tween the nude mice (Ps 0.05) before treatment. The
nodule volumes were listed after 3, 7, 14 and 21 day
photodynamic therapeutic treatment, respectively.
Upon exposure to laser light, the nodules of the
nude mice that had undergone BAHA injection de-
creased to some extent. Di¡erences in nodule size
became notable as a function of time. The data
showed a signi¢cant decrease in the growth of pan-
creatic nodules. Fig. 7 displays the nude mice with
orthotopically transplanted pancreatic cancer under-
going intratumor photodynamic therapy after direct
injection of BAHA compared with those without
treatment. A control experiment indicated that light,
sensitizer and oxygen were all important for the pho-
todynamic therapy.
Fig. 6. Intratumor photodynamic therapy of subcutaneous and
orthotopic human pancreatic tumor nodules in vivo. A, no
treatment was applied to the nude mice; B, only laser light was
applied to the nude mice; C, photodynamic therapy with HA
(30 mg/kg) and laser light was applied to the nude mice; D, the
same as C but HA was replaced by BAHA (30 mg/kg). Set-
tings: V= 632.8 nm; optical energy density: 120 J/cm2 ; illumi-
nation area: 2 cm2 ; illumination mode: ambulating above the
center of the tumor.
Fig. 5. E¡ects of increasing concentration of BAHB on Capan-1 cell survival of irradiated pancreatic tumor cells.
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4. Conclusion
A simple and mild amination pathway was em-
ployed to synthesize 2-butylamino-2-demethoxy-hy-
pocrellin A and B (BAHy). In BAHy molecules the
peri-hydroxylated perylenequinone structure of the
parent hypocrellin was preserved, which may play
an important role in their photodynamic action [4^
7]. Moreover, when an electron-donating butylamino
group was introduced into hypocrellin molecules, it
not only expanded the photoresponse of hypocrel-
lins, but also enhanced their ability to generate
Fig. 7. Nude mice with orthotopically transplanted pancreatic cancer undergoing (A) no photodynamic therapy, (B) intratumor photo-
dynamic therapy after direct injection of BAHA.
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Oc32 . Both in vitro and in vivo results revealed that
BAHy exhibited much higher photodynamic activity
than their parent hypocrellins. It is suggested that the
type I mechanism played a signi¢cant role in photo-
dynamic therapy as well as the type II mechanism.
All the results quali¢ed the aminated hypocrellins as
more potent photodynamic therapeutic agents than
their parent hypocrellins.
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